Cutler Group LP Organon & Co. Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$23.31 - $28.61 $109,253 - $134,095	-4,687 Reduced 57.53%	3,460 $96,000
Q3 2022 Oct 25, 2022	BUY	$23.4 - $34.25 $28,782 - $42,127	1,230 Added 17.78%	8,147 $190,000
Q2 2022 Aug 04, 2022	BUY	$31.66 - $38.9 $119,263 - $146,536	3,767 Added 119.59%	6,917 $233,000
Q1 2022 Apr 14, 2022	BUY	$30.45 - $39.36 $68,208 - $88,166	2,240 Added 246.15%	3,150 $110,000
Q4 2021 Jan 18, 2022	BUY	$28.67 - $37.13 $26,089 - $33,788	910 New	910 $27,000
Q3 2021 Oct 26, 2021	SELL	$28.63 - $35.64 $223,657 - $278,419	-7,812 Closed	0 $0
Q2 2021 Jul 19, 2021	BUY	$28.45 - $38.0 $222,251 - $296,856	7,812 New	7,812 $236,000

790

201M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.17B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.